Second primary tumors in laryngeal cancer: Results of long-term follow- up

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 3, 1998, Pages 557-562

  Narayana, Ashwatha ^a   Vaughan, Andrew T M ^a   Fisher, Susan G ^a   Reddy, Sarada P ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Laryngeal cancer; p53; Radiotherapy; Second primary tumor

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; INCIDENCE; LARYNX CANCER; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; VOCAL CORDS;

EID: 0031724264     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00250-8     Document Type: Article

References (28)

1. Borina CC, Savines TS, Tong T. Cancer statistics 1994. CA Cancer J Clin 1996;447-526.
2. Reddy SP, Mohideen N, Marra S, et al. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer. Radiother Oncol 1998;47:161-166.
3. Rudoltz MD, Benammar A, Mohiuddin M. Prognostic factors for local control and survival in T1 squamous cell carcinoma of the glottis. Int J Radiat Oncol Biol Phys 1993;16:762-72.
4. Stevenson JM, Juillard GY, Selch MT. Stages 1 and 2 epidermoid carcinoma of the glottic larynx: Involvement of the anterior commissure. Radiology 1992;182:797-799.
5. Kotwall C, Razack MS, Sako K, et al. Multiple primary cancers in squamous cell cancer of the head and neck. J Surg Oncol 1989;40:97-99.
6. Licciardello JW, Spitz MR, Hong WK. Multiple primary cancer in patients with cancer of the head and neck: Second cancer of the head and neck, esophagus, and lung. Int J Radiat Oncol Biol Phys 1989;17:467-476.
7. Carey T. Field cancerization: Are multiple primaries monoclonal or polyclonal? Ann Med 1996;28:183-188.
8. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 1990;32:795-801.
9. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989;17:449-456.
10. Schwartz LH, Ozsahin M, Zhang GN, et al. Synchronous and metachronous head and neck carcinomas. Cancer 1994;74:1933-1938.
11. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium. Cancer 1953;6:963-968.
12. Sidransky D, Frost P, Von Eschenback A, et al. Clonal origin of bladder cancer. N Engl J Med 1992;326:737-740.
13. Worsham MJ, Wolman SR, Carney TE, et al. Common clonal origin of synchronous primary head and neck squamous cell carcinomas: Analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol 1995;16:251-261.
14. Watling DL, Gowan AM, Coltrera P. Overexpression of p53 in head and neck cancer. Head Neck 1992;16:437-444.
15. Chung KY, Mukhopadhyay T, Jhingook K, et al. Discordant p53 mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993;53:1676-1683.
16. Koch WM, Boyle JO, Mao L, et al. p53 gene mutations as markers of tumor spread in synchronous oral cancers. Arch Otolaryngol Head Neck Surg 1994;120:943-947.
17. Narayana A, Vaughan ATM, Gunaratne S, et al. Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer 1988;82:279-284.
18. Warren S, Gates O. Multiple primary malignant tumors: Survey of literature and statistical study. Am J Cancer 1932;16:1358-1414.
19. Travis LB, Curtis RE, Storm H, et al. Risk of second malignant neoplasm among long term survivors of testicular cancer. J Natl Cancer Inst 1997;89:1429-1439.
20. Parker RA, Enstrom JE. Second primary cancers of the head and neck following treatment of initial primary head and neck cancers. Int J Radiat Oncol Biol Phys 1988;14:561-564.
21. Roberts TJ, Epstein B, Lee DJ. Second neoplasms in patients with carcinomas of the vocal cord; incidence and implications for survival. Int J Radiat Oncol Biol Phys 1991;21:583-589.
22. Hong WK, Endicott J, Itri L, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986;315:1501-1505.
23. Benner SE, Pajak TF, Lippman S, et al. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: Long-term follow-up. J Natl Cancer Inst 1994;86:140-141.
24. Boysen M, Loven JO. Second malignant neoplasms in patients with head and neck squamous cell carcinomas. Acta Oncol 1993;32-33;283-288.
25. McDonald S, Haie C, Rubin P. Second malignant tumors in patients with laryngeal carcinoma: Diagnosis, treatment, and prevention. Int J Radiat Oncol Biol Phys 1989;17:457-465.
26. Boyle JO, Hakin J, Koch W, et al. The incidence of p53 mutations increases with tumor progression of head and neck cancer. Cancer Res 1997;40:1872-1878.
27. Wynder EL, Mushinski MH, Spivak JC. Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer Res 1977;40:1872-1878.
28. Colucci S, el-Gehani R, Flint S, et al. p53 mutation and protein expression in primary cultures of normal oral mucosa in smokers and non-smokers. Oral Oncol 1997;33:240-246.